According to a new research report by RNCOS “US Cardiac Device Market Analysis”,
the cardiac medical devices market in the US has become one of the prominent segments in the healthcare industry, which is primarily boosted by rising incidences of cardiovascular indications. Backed by supporting drivers, in 2011, the US market for cardiac devices was estimated to have reached around US$ 17.5 Billion. In future, shortcoming in existing drug therapies shall promote the usage of cardiac medical devices in the US hospitals.
As per our report, the US interventional cardiology market, which includes PTCA balloons, coronary stents, cardiac catheters, and peripheral vascular devices, has grown significantly in recent times fueled by demographic, technologic, and economic factors. The segment is dominated by coronary stents, which in turn, contribute good proportion of revenue in the US interventional cardiology market.
The report, which is spread in over 70 pages, prudently analyzes the current performance of market segments (cardiac rhythm management, interventional cardiology and cardiovascular surgery) and the share of other sub-segments. It also elaborates, in detail, regulatory landscape with regards to cardiac medical devices in the US and the role of key authorities/association in the decision making process.
The report is an outcome of an extensive research and rational analysis of the current status and expected position of the US cardiac medical devices market. It facilitates the future forecasts on overall US cardiac medical devices market size during 2012-2015. It also covers an in-depth analysis of the competitive landscape and broadly elaborates about the players in terms of their business description, financial performance, strengths & weaknesses and key activities.
Some of our Related Reports are:
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm